These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28033393)

  • 1. Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.
    Parsons E; Otieno JA; Ong'echa JM; Nixon CE; Vulule J; Münz C; Stewart VA; Moormann AM
    PLoS One; 2016; 11(12):e0167841. PubMed ID: 28033393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.
    Moormann AM; Heller KN; Chelimo K; Embury P; Ploutz-Snyder R; Otieno JA; Oduor M; Münz C; Rochford R
    Int J Cancer; 2009 Apr; 124(7):1721-6. PubMed ID: 19089927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.
    Snider CJ; Cole SR; Chelimo K; Sumba PO; Macdonald PD; John CC; Meshnick SR; Moormann AM
    PLoS One; 2012; 7(3):e31753. PubMed ID: 22427806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.
    Piriou E; Asito AS; Sumba PO; Fiore N; Middeldorp JM; Moormann AM; Ploutz-Snyder R; Rochford R
    J Infect Dis; 2012 Mar; 205(6):906-13. PubMed ID: 22301635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
    Moormann AM; Chelimo K; Sumba PO; Tisch DJ; Rochford R; Kazura JW
    J Infect Dis; 2007 Mar; 195(6):799-808. PubMed ID: 17299709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4
    Forconi CS; Mulama DH; Saikumar Lakshmi P; Foley J; Otieno JA; Kurtis JD; Berg LJ; Ong'echa JM; Münz C; Moormann AM
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
    Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer.
    Mulama DH; Bailey JA; Foley J; Chelimo K; Ouma C; Jura WG; Otieno J; Vulule J; Moormann AM
    Int J Cancer; 2014 Feb; 134(3):645-53. PubMed ID: 23832374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya.
    Redmond LS; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Masalu N; Kawira E; Otim I; Legason ID; Dhudha H; Ayers LW; Bhatia K; Goedert JJ; Mbulaiteye SM
    Malar J; 2020 Jul; 19(1):239. PubMed ID: 32718346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.
    Muriuki BM; Forconi CS; Oluoch PO; Bailey JA; Ghansah A; Moormann AM; Ong'echa JM
    Sci Rep; 2021 May; 11(1):11343. PubMed ID: 34059753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
    Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
    Malar J; 2007 May; 6():69. PubMed ID: 17521425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies.
    Derkach A; Otim I; Pfeiffer RM; Onabajo OO; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Talisuna AO; Ayers LW; Reynolds SJ; Nkrumah F; Neequaye J; Bhatia K; Theander TG; Prokunina-Olsson L; Turner L; Goedert JJ; Lavstsen T; Mbulaiteye SM
    EBioMedicine; 2019 Jan; 39():358-368. PubMed ID: 30579868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.
    Chattopadhyay PK; Chelimo K; Embury PB; Mulama DH; Sumba PO; Gostick E; Ladell K; Brodie TM; Vulule J; Roederer M; Moormann AM; Price DA
    J Virol; 2013 Feb; 87(3):1779-88. PubMed ID: 23175378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia.
    Ateyah ME; Hashem ME; Abdelsalam M
    J Clin Pathol; 2017 Feb; 70(2):120-125. PubMed ID: 27458150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.
    Buckle G; Maranda L; Skiles J; Ong'echa JM; Foley J; Epstein M; Vik TA; Schroeder A; Lemberger J; Rosmarin A; Remick SC; Bailey JA; Vulule J; Otieno JA; Moormann AM
    Int J Cancer; 2016 Sep; 139(6):1231-40. PubMed ID: 27136063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly cytotoxic terminally differentiated CD56
    Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
    Blood Adv; 2018 May; 2(10):1101-1114. PubMed ID: 29764843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Combined Effect of Epstein-Barr Virus and
    Aguilar R; Casabonne D; O'Callaghan-Gordo C; Vidal M; Campo JJ; Mutalima N; Angov E; Dutta S; Gaur D; Chitnis CE; Chauhan V; Michel A; de Sanjosé S; Waterboer T; Kogevinas M; Newton R; Dobaño C
    Front Immunol; 2017; 8():1284. PubMed ID: 29123514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
    Kaymaz Y; Oduor CI; Yu H; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
    Mol Cancer Res; 2017 May; 15(5):563-576. PubMed ID: 28465297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.
    Muriuki BM; Forconi CS; Kirwa EK; Maina TK; Ariera BO; Bailey JA; Ghansah A; Moormann AM; Ong'echa JM
    PLoS One; 2023; 18(8):e0275046. PubMed ID: 37647275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.